*Editor*

Coronavirus disease 2019 (COVID‐19) is now a global pandemic[1](#bjs11643-bib-0001){ref-type="ref"}. To cope with increasing medical demand, many operations have been postponed. We retrospectively analysed patients who received abdominal emergency surgery in Wuhan, China between 15 January and 15 March 2020, including eight patients with COVID‐19 and 22 uninfected patients.

Patients\' baseline characteristics are listed in *Table* [1](#bjs11643-tbl-0001){ref-type="table"}. All COVID‐19 patients had typical ground glass opacity changes on thorax CT[2](#bjs11643-bib-0002){ref-type="ref"}. Five patients had low grade fever (below 38·5°C), two patients had a cough, and one patient was critically ill with an *Sp* [o]{.smallcaps} ~2~ of 88% immediately before surgery. Duration of surgery was similar in infected and uninfected patients. As shown in *Table* [2](#bjs11643-tbl-0002){ref-type="table"}, before surgery, C‐reactive protein (CRP) levels were higher in patients with COVID‐19, but remained stable 3 days after surgery. In the uninfected group, there were raised CRP levels after surgery, which is a common postoperative variation. In addition, the percentage of lymphocytes was decreased in patients with COVID‐19 but not in uninfected patients. We observed higher aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in COVID‐19 groups, but this could be caused by the primary disease. As shown in *Fig*. [1](#bjs11643-fig-0001){ref-type="fig"}, after surgery, ground glass opacity, a typical CT image change in patients with COVID‐19, remained stable or decreased slightly in all mild cases. In both groups, we observed pleural effusion and atelectasis on CT, these postoperative changes were distinguished from the unique changes seen in viral pneumonia. All but the critically ill patient with COVID‐19 recovered without respiratory support.

###### 

Baseline characteristics of patients

                                                                      Infected (*n* = 8)   Uninfected (*n* = 22)
  ------------------------------------------------------------------ -------------------- -----------------------
  Age (years)[\*](#bjs11643-note-0002){ref-type="fn"}                    68 (67--69)            48 (41--64)
  M : F                                                                     2 : 6                 8 : 14
  BMI (kg/m^2^)[†](#bjs11643-note-0003){ref-type="fn"}                   24·04(1·95)            22·91(3·92)
  Smoking                                                                                 
  Smoker                                                                      1                      5
  Non‐smoker                                                                  7                     17
  Comorbidity                                                                             
  Diabetes                                                                    0                      4
  Hypertension                                                                2                      5
  Cardiovascular disease                                                      0                      1
  Chronic obstructive pulmonary disease                                       0                      0
  Malignancy                                                                  2                      5
  Symptoms at admission                                                                   
  Fever                                                                       5                      2
  Cough                                                                       2                      0
  Shortness of breath                                                         1                      0
  Abdominal pain                                                              7                      3
  Previous surgery                                                                        
  Yes                                                                         4                     13
  No                                                                          4                      8
  Intervention                                                                            
  Appendectomy                                                                2                      6
  Gastrectomy                                                                 1                      0
  Enterocolectomy                                                             2                      8
  Cholecystostomy                                                             1                      1
  Pancreaticojejunostomy                                                      1                      1
  Gastric perforation repair                                                  1                      6
  Peritoneal contamination (yes : no)                                                     
  Yes                                                                         4                     17
  No                                                                          4                      5
  Duration of surgery (min)[†](#bjs11643-note-0003){ref-type="fn"}       137·0(87·0)            164·0(92·6)

Values are

median (i.q.r.) or

mean(s.d.).

###### 

Laboratory results of patients before and after surgery

                                          Infected (*n* = 8)   Uninfected (*n* = 22)                                                         
  -------------------------------------- -------------------- ----------------------- ------------------------------------------------------ ------------------------------------------------------
  White blood cells (×10^9^/l)               10·68(5·23)            12·54(3·16)                            10·36(5·19)                                            10·09(3·15)
  Lymphocytes (%)                            11·85(6·82)            7·75(1·56)                             14·35(11·75)                       11·38(5·91)[\*](#bjs11643-note-0005){ref-type="fn"}
  Neutrophils (%)                            84·04(7·72)            86·93(3·03)                            79·41(15·31)                                           81·92(7·73)
  Basophils (%)                               0·09(0·11)            0·09(0·11)                              0·13(0·16)                                             0·11(0·10)
  Eosnophil                                   0·54(0·96)            0·60(0·88)                              0·88(1·48)                                             1·09(1·59)
  Monocyte                                    3·48(1·58)            4·60(1·77)                              5·29(3·06)                                             5·53(2·19)
  Platelets (×10^9^/l)                      257·38(155·36)         168·88(97·13)                          213·14(61·98)                                          185·32(74·52)
  Total bilirubin (μmol/l)                   23·22(13·47)          18·05(25·27)                            20·53(13·52)                                           17·25(10·70)
  C‐reactive protein (mg/l)                 100·06(93·98)          104·41(64·39)       55·12(119·12)[†](#bjs11643-note-0006){ref-type="fn"}   163·74(94·50)[‡](#bjs11643-note-0007){ref-type="fn"}
  Alanine aminotransferase (units/l)         54·75(96·28)          42·38(59·67)                            19·91(8·43)                                            22·64(9·33)
  Aspartate aminotransferase (units/l)       53·38(84·85)          39·25(35·81)                            21·27(10·00)                                           22·45(9·48)
  Blood albumin (g/l)                        35·75(5·01)            26·26(4·06)                            40·13(6·34)                                            30·09(6·47)
  Blood urea nitrogen (mmol/l)                6·92(2·44)            6·24(2·74)                              7·29(5·97)                                             7·11(3·83)
  Serum creatinine (μmol/l)                  88·26(64·42)          56·58(16·97)                           107·45(99·36)                                           71·30(36·03)
  Clinical outcomes                                                                                                                          
  Cured/improved                                  7                                                                                                                    19
  Died                                            1                                                                                                                    3

Values in parentheses are mean(s.d.). Laboratory tests were undertaken 3 days after surgery.

*P*  = 0·014 *versus* infected group after surgery.

*P*  = 0·019 *versus* infected group before surgery.

*P*  = 0·035 *versus* uninfected group before surgery (Mann‐Whitney *U* test).

![Pre‐ and postoperative CT in COVID‐19 patients **a** 69‐year‐old woman before surgery, showing ground glass opacity (arrowhead). **b** Ground glass opacity was decreased slightly 7 days after surgery (arrowhead). **c** 68‐year‐old man before surgery, showing ground glass opacity (arrowhead). **d** Ground glass opacity remained stable 7 days after surgery (arrowhead). **e** Normal CT in 62‐year‐old man. **f** Pleural effusion 5 days after surgery (arrowhead).](BJS-107-e183-g001){#bjs11643-fig-0001}

These data contribute information to help general surgeons in the area affected by the pandemic assess the safety of surgery. For mildly infected or asymptomatic patients, postoperative recovery seemed not to be affected. The study is limited by a lack of clinical cases due to our previous overly conservative attitude. We recommend general surgeons be more positive when making surgical decisions. Hospital mortality might be higher not because of COVID‐19, but because of the panic caused by COVID‐19.
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